VeriMomVeriMom

¿Es resveratryl tris-ethylhexanoate seguro durante el embarazo?

No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.

Ingredientes
resveratryl tris-ethylhexanoate
RIESGO MEDIO
67
/100
0

Alternativas seguras a resveratryl tris-ethylhexanoate en el embarazo | VeriMom

Related ingredients

Frequently asked questions

¿Es resveratryl tris-ethylhexanoate seguro durante el embarazo?
No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.
¿Es resveratryl tris-ethylhexanoate seguro durante la lactancia?
Same justification as pregnancy: no direct reproductive/breastmilk transfer data for this specific ingredient. Because it is a resveratrol derivative, a conservative structural/class alert is applied (h=1) and mechanism remains theoretical (m=1). Exposure from topical application to the breast is expected to be low but measurable (e=1); no data were found on transfer into breastmilk for this ester.
¿Es resveratryl tris-ethylhexanoate seguro para la piel del bebé?
No infant‑specific safety studies for resveratryl tris‑ethylhexanoate were identified. Hazard and mechanism scores remain the same as adult (h=1, m=1) because there is no infant‑specific evidence of increased hazard or a different mechanism. Exposure score is increased by +1 (e=2) to account for higher per‑weight exposure and immature barrier in 0–3‑year‑old skin when the ingredient has measurable dermal absorption in adults.
¿Cómo puntúa VeriMom a resveratryl tris-ethylhexanoate?
VeriMom puntúa resveratryl tris-ethylhexanoate en 67/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
¿Cuáles son las alternativas seguras a resveratryl tris-ethylhexanoate en el embarazo?
Consulta nuestra lista de alternativas seguras a resveratryl tris-ethylhexanoate según función similar y clasificación sin riesgos conocidos.

Comprueba cualquier etiqueta en 2 segundos

Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.

Aviso Médico

Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.

Obtén la experiencia completa en la app VeriMom